E-selectin antagonist compounds, compositions, and methods of use Patent Grant Magnani , et al. Sep [GlycoMimetics, Inc.]

4.8 (550) ·
$ 7.00 ·
In stock

Description

E-selectin antagonist compounds, compositions, and methods of use Patent  Grant Magnani , et al. Sep [GlycoMimetics, Inc.]
WO2012061662A1 - Glycomimetic-peptidomimetic inhibitors of e-selectins and cxcr4 chemokine receptors - Google Patents
E-selectin antagonist compounds, compositions, and methods of use Patent  Grant Magnani , et al. Sep [GlycoMimetics, Inc.]
Pharmaceuticals, Free Full-Text
E-selectin antagonist compounds, compositions, and methods of use Patent  Grant Magnani , et al. Sep [GlycoMimetics, Inc.]
E-selectin antagonist compounds, compositions, and methods of use Patent Grant Magnani , et al. Sep [GlycoMimetics, Inc.]
E-selectin antagonist compounds, compositions, and methods of use Patent  Grant Magnani , et al. Sep [GlycoMimetics, Inc.]
US9534009B2 - Pan-selectin inhibitor with enhanced pharmacokinetic activity - Google Patents
E-selectin antagonist compounds, compositions, and methods of use Patent  Grant Magnani , et al. Sep [GlycoMimetics, Inc.]
Glycomimetics for the inhibition and modulation of lectins - Chemical Society Reviews (RSC Publishing) DOI:10.1039/D2CS00954D
E-selectin antagonist compounds, compositions, and methods of use Patent  Grant Magnani , et al. Sep [GlycoMimetics, Inc.]
WO2013096926A1 - E-selectin antagonist compounds, compositions, and methods of use - Google Patents
E-selectin antagonist compounds, compositions, and methods of use Patent  Grant Magnani , et al. Sep [GlycoMimetics, Inc.]
PDF) Targeting E-Selectin to Tackle Cancer Using Uproleselan
E-selectin antagonist compounds, compositions, and methods of use Patent  Grant Magnani , et al. Sep [GlycoMimetics, Inc.]
WO2013096926A1 - E-selectin antagonist compounds, compositions, and methods of use - Google Patents
E-selectin antagonist compounds, compositions, and methods of use Patent  Grant Magnani , et al. Sep [GlycoMimetics, Inc.]
PDF) The vascular bone marrow niche influences outcome in chronic myeloid leukemia via the E-selectin - SCL/TAL1 - CD44 axis
E-selectin antagonist compounds, compositions, and methods of use Patent  Grant Magnani , et al. Sep [GlycoMimetics, Inc.]
E-selectin antagonist compounds, compositions, and methods of use Patent Grant Magnani , et al. Sep [GlycoMimetics, Inc.]
E-selectin antagonist compounds, compositions, and methods of use Patent  Grant Magnani , et al. Sep [GlycoMimetics, Inc.]
The clinical impact of glycobiology: targeting selectins, Siglecs and mammalian glycans
E-selectin antagonist compounds, compositions, and methods of use Patent  Grant Magnani , et al. Sep [GlycoMimetics, Inc.]
WO2005051920A2 - Specific antagonist for both e- and p-selectins - Google Patents
E-selectin antagonist compounds, compositions, and methods of use Patent  Grant Magnani , et al. Sep [GlycoMimetics, Inc.]
E-SELECTIN ANTAGONIST COMPOUNDS - Patent 2794626
E-selectin antagonist compounds, compositions, and methods of use Patent  Grant Magnani , et al. Sep [GlycoMimetics, Inc.]
PDF) Targeting E-Selectin to Tackle Cancer Using Uproleselan

Related products

You may also like

copyright © 2019-2024 richy.com.vn all rights reserved.